Richard L. Raymond

Array ( [id] => 3492052 [patent_doc_number] => 05470977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes, 3-aminochromanes and 3-aminothiochromanes' [patent_app_type] => 1 [patent_app_number] => 8/404390 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11871 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 243 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470977.pdf [firstpage_image] =>[orig_patent_app_number] => 404390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3872665 [patent_doc_number] => 05763485 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-09 [patent_title] => 'Method of treating catabolic, gut-associated pathological processes and impaired host defenses' [patent_app_type] => 1 [patent_app_number] => 8/402827 [patent_app_country] => US [patent_app_date] => 1995-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 31350 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/763/05763485.pdf [firstpage_image] =>[orig_patent_app_number] => 402827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3651412 [patent_doc_number] => 05639915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Process for the production of aniline derivatives' [patent_app_type] => 1 [patent_app_number] => 8/401781 [patent_app_country] => US [patent_app_date] => 1995-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7739 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 149 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639915.pdf [firstpage_image] =>[orig_patent_app_number] => 401781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3540671 [patent_doc_number] => 05480912 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-02 [patent_title] => 'Method of treating HIV-1 with .alpha.-substituted benzenemethanamine derivatives' [patent_app_type] => 1 [patent_app_number] => 8/400218 [patent_app_country] => US [patent_app_date] => 1995-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10669 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 534 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/480/05480912.pdf [firstpage_image] =>[orig_patent_app_number] => 400218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3431183 [patent_doc_number] => 05463130 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-10-31 [patent_title] => 'Preparation of peralkylated amines' [patent_app_type] => 1 [patent_app_number] => 8/395596 [patent_app_country] => US [patent_app_date] => 1995-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3827 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 482 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/463/05463130.pdf [firstpage_image] =>[orig_patent_app_number] => 395596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3745412 [patent_doc_number] => 05801243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Photochromic compounds (7)' [patent_app_type] => 1 [patent_app_number] => 8/393010 [patent_app_country] => US [patent_app_date] => 1995-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1724 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801243.pdf [firstpage_image] =>[orig_patent_app_number] => 393010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3445678 [patent_doc_number] => 05466872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-14 [patent_title] => 'Poly (oxyalkylene) aromatic ethers' [patent_app_type] => 1 [patent_app_number] => 8/395368 [patent_app_country] => US [patent_app_date] => 1995-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6996 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/466/05466872.pdf [firstpage_image] =>[orig_patent_app_number] => 395368 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3857298 [patent_doc_number] => 05705518 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-06 [patent_title] => 'Method of activating photosensitive agents' [patent_app_type] => 1 [patent_app_number] => 8/391414 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 5312 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/705/05705518.pdf [firstpage_image] =>[orig_patent_app_number] => 391414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589790 [patent_doc_number] => 05550242 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-27 [patent_title] => 'Process for the preparation of polyalkyl-1-oxa-diazaspirodecane compounds' [patent_app_type] => 1 [patent_app_number] => 8/390404 [patent_app_country] => US [patent_app_date] => 1995-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6700 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 701 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/550/05550242.pdf [firstpage_image] =>[orig_patent_app_number] => 390404 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662033 [patent_doc_number] => 05656643 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase' [patent_app_type] => 1 [patent_app_number] => 8/385258 [patent_app_country] => US [patent_app_date] => 1995-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9252 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656643.pdf [firstpage_image] =>[orig_patent_app_number] => 385258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3690971 [patent_doc_number] => 05663443 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Ruthenium catalysts, their preparation and a process for preparing cycloaliphatic polyamines using these catalysts' [patent_app_type] => 1 [patent_app_number] => 8/384303 [patent_app_country] => US [patent_app_date] => 1995-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3086 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663443.pdf [firstpage_image] =>[orig_patent_app_number] => 384303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3567510 [patent_doc_number] => 05484803 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-01-16 [patent_title] => 'Transcutaneous in vivo activation of photosensitive agents in blood' [patent_app_type] => 1 [patent_app_number] => 8/384440 [patent_app_country] => US [patent_app_date] => 1995-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6653 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/484/05484803.pdf [firstpage_image] =>[orig_patent_app_number] => 384440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3817548 [patent_doc_number] => 05770630 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Manufacture of organic liquids' [patent_app_type] => 1 [patent_app_number] => 8/383694 [patent_app_country] => US [patent_app_date] => 1995-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5717 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770630.pdf [firstpage_image] =>[orig_patent_app_number] => 383694 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3614489 [patent_doc_number] => 05510372 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-04-23 [patent_title] => 'Antiparasitic macrolide antiobiotics' [patent_app_type] => 1 [patent_app_number] => 8/378997 [patent_app_country] => US [patent_app_date] => 1995-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9159 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/510/05510372.pdf [firstpage_image] =>[orig_patent_app_number] => 378997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3560310 [patent_doc_number] => 05502233 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-26 [patent_title] => 'Enamine intermediates for the preparation of substituted pyridylpyrimidines' [patent_app_type] => 1 [patent_app_number] => 8/376583 [patent_app_country] => US [patent_app_date] => 1995-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6330 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 168 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/502/05502233.pdf [firstpage_image] =>[orig_patent_app_number] => 376583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3669422 [patent_doc_number] => 05599993 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-04 [patent_title] => 'Phenylethynyl amine' [patent_app_type] => 1 [patent_app_number] => 8/376167 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8835 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/599/05599993.pdf [firstpage_image] =>[orig_patent_app_number] => 376167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549189 [patent_doc_number] => 05545745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-13 [patent_title] => 'Enantioselective preparation of optically pure albuterol' [patent_app_type] => 1 [patent_app_number] => 8/376072 [patent_app_country] => US [patent_app_date] => 1995-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3905 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/545/05545745.pdf [firstpage_image] =>[orig_patent_app_number] => 376072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3512381 [patent_doc_number] => 05563268 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-08 [patent_title] => 'Heterobiaryl derivatives' [patent_app_type] => 1 [patent_app_number] => 8/375084 [patent_app_country] => US [patent_app_date] => 1995-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20006 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/563/05563268.pdf [firstpage_image] =>[orig_patent_app_number] => 375084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3913468 [patent_doc_number] => 06001860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-14 [patent_title] => 'N-aryl and N-heteroarylurea derivatives as inhibitors of acyl coenzyme A: Cholesterol acyl transferase (ACAT)' [patent_app_type] => 1 [patent_app_number] => 8/343557 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22118 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 659 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/001/06001860.pdf [firstpage_image] =>[orig_patent_app_number] => 343557 [rel_patent_id] =>[rel_patent_doc_number] =>)